hyperdemocracy/usc-billstatus huggingface dataset:
Investing in American Workers Act

Bill: 117-s-1422
Sponsor: Sen. Warner, Mark R. [D-VA]
Introduced: 2021-04-28 in the Senate
Policy area: Taxation
Subjects: Employment and training programs
Employment taxes
Higher education
Income tax credits
Income tax rates
Licensing and registrations
Small business
Tax-exempt organizations

Summary:
action_date: 2021-04-28
text: 

Investing in American Workers Act 

 
This bill allows a business-related tax credit for employers who increase worker training expenditures.
 
The credit is equal to 20% of the excess of (1) the qualified training expenditures for the year, over (2) the average of the adjusted qualified training expenditures for the three previous years. If the employer had no qualified training expenditures in any one of the three previous years, the credit is equal to 10% of the adjusted qualified training expenditures for the year. 
 
The credit applies to expenditures for the training of non-highly compensated employees (annual compensation does not exceed $82,000). The training must result in the attainment of a recognized postsecondary credential and be provided through
 
 
an apprenticeship program; 
 
 a program of training services that is included on a list of eligible training providers that states are required to maintain under the Workforce Innovation and Opportunity Act; 
 
 a program that is conducted by an area career and technical education school, a community college, or a labor organization; or 
 
 a program that is sponsored and administered by an employer, industry trade association, industry or sector partnership, or labor organization. 
 
 
Certain small businesses and tax-exempt organizations may apply the credit against payroll taxes, subject to specified limits and requirements. Eligible small businesses may also apply the credit against the alternative minimum tax.


Legislative actions:
action_date: 2022-03-22
text: Committee on Banking, Housing, and Urban Affairs. Hearings held.
action_date: 2021-04-28
text: Read twice and referred to the Committee on Finance.
action_date: 2021-04-28
text: Introduced in Senate
Clean Slate for Kids Online Act of 2021

Bill: 117-s-1423
Sponsor: Sen. Durbin, Richard J. [D-IL]
Introduced: 2021-04-28 in the Senate
Policy area: Science, Technology, Communications
Subjects: Child safety and welfare
Internet and video services
Internet, web applications, social media
Right of privacy

Summary:
action_date: 2021-04-28
text: 

Clean Slate for Kids Online Act of 2021

 
This bill allows individuals over age 13 (or their guardians, if applicable) to request the deletion of information collected from or about them while they were under age 13 by a website or online service that is directed to children. 
 
Specifically, the bill requires an operator of such a website or service to
 
 
provide notice on their website about how an individual over age 13 (or the guardian of an individual over age 13) can request the deletion of all personal information in the operator's possession collected when the individual was under age 13; 
 
promptly delete, upon request, all such personal information; and 
 
provide written confirmation of deletion.

 
The bill allows a limited exception to the deletion requirement if the personal information collected from or about a child is necessary to (1) respond to a judicial process, or (2) to provide information to law enforcement agencies or for an investigation related to public safety. 


Legislative actions:
action_date: 2021-04-28
text: Read twice and referred to the Committee on Commerce, Science, and Transportation. (text: CR S2295)
action_date: 2021-04-28
text: Introduced in Senate
Chronic Disease Management Act of 2021

Bill: 117-s-1424
Sponsor: Sen. Thune, John [R-SD]
Introduced: 2021-04-28 in the Senate
Policy area: Taxation
Subjects: Health care costs and insurance
Health care coverage and access
Health promotion and preventive care
Income tax deductions

Summary:
action_date: 2021-04-28
text: 

Chronic Disease Management Act of 2021

 
 This bill modifies requirements for health savings accounts (HSAs) to permit the high deductible health plans required for an HSA to provide care for chronic conditions with no deductible. The bill covers any preventive care service or item used to treat a chronic condition if (1) such service or item is low-cost, (2) there is medical evidence of the effectiveness of such service or item, and (3) there is a strong likelihood that the use of such service or item will prevent the exacerbation of the chronic condition or the development of a secondary condition that requires significantly higher cost treatment. The bill further provides that an individual who has been prescribed preventive care for any chronic condition may be presumed to have been diagnosed with such condition if such preventive care is customarily prescribed for such condition.


Legislative actions:
action_date: 2021-04-28
text: Read twice and referred to the Committee on Finance. (text: CR S2295)
action_date: 2021-04-28
text: Introduced in Senate
Stop STALLING Act

Bill: 117-s-1425
Sponsor: Sen. Klobuchar, Amy [D-MN]
Introduced: 2021-04-28 in the Senate
Policy area: Health
Subjects: Administrative remedies
Business ethics
Civil actions and liability
Competition and antitrust
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Licensing and registrations
Prescription drugs
Public participation and lobbying

Summary:
action_date: 2021-04-28
text: 

Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the
 
Stop STALLING Act

 
This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.
 
The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.

action_date: 2021-12-08
text: 

Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the
 
Stop STALLING Act

 
This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.
 
The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.


Legislative actions:
action_date: 2021-12-08
text: Placed on Senate Legislative Calendar under General Orders. Calendar No. 179.
action_date: 2021-12-08
text: Committee on the Judiciary. Reported by Senator Durbin without amendment. Without written report.
action_date: 2021-12-08
text: Committee on the Judiciary. Reported by Senator Durbin without amendment. Without written report.
action_date: 2021-07-29
text: Committee on the Judiciary. Ordered to be reported without amendment favorably.
action_date: 2021-04-28
text: Read twice and referred to the Committee on the Judiciary.
action_date: 2021-04-28
text: Introduced in Senate
Parent Tax Credit Act

Bill: 117-s-1426
Sponsor: Sen. Hawley, Josh [R-MO]
Introduced: 2021-04-28 in the Senate
Policy area: Taxation
Subjects: Income tax credits
Inflation and prices
Tax treatment of families

Summary:
action_date: 2021-04-28
text: 

Parent Tax Credit Act

 
This bill allows an eligible individual a tax credit of $6,000 ($12,000 in the case of a joint tax return), with a limitation based on a minimum earned income level. The bill defines
 eligible individual
 as any individual who has a qualifying child who is not yet 13. The eligible individual may not be a nonresident alien, any alien unlawfully present in the United States, and any individual who is a dependent of another taxpayer. To be eligible for the credit, the taxpayer must include on the return of tax a valid Social Security account number.
 
The bill requires the Internal Revenue Service to establish a program for making advance payments of the credit to taxpayers on a monthly basis.
 
The bill terminates the child and dependent care tax credit after 2021.


Legislative actions:
action_date: 2021-04-28
text: Read twice and referred to the Committee on Finance.
action_date: 2021-04-28
text: Introduced in Senate
Increasing Access to Biosimilars Act of 2021

Bill: 117-s-1427
Sponsor: Sen. Cornyn, John [R-TX]
Introduced: 2021-04-28 in the Senate
Policy area: Health
Subjects: Congressional oversight
Government studies and investigations
Health care costs and insurance
Health information and medical records
Health programs administration and funding
Medicare
Prescription drugs

Summary:
action_date: 2021-04-28
text: 

Increasing Access to Biosimilars Act of 

2021

 
This bill requires the Centers for Medicare & Medicaid Services to establish a demonstration project to evaluate the benefits of providing additional payments to providers of biosimilars under Medicare. Specifically, under the demonstration project, participating providers receive an additional payment based on the difference between the costs to the provider of furnishing the biosimilar and the cost if the provider had furnished the underlying reference biological product instead. 


Legislative actions:
action_date: 2021-04-28
text: Read twice and referred to the Committee on Finance.
action_date: 2021-04-28
text: Introduced in Senate
Justice for the Living Victims of Lockerbie Act

Bill: 117-s-1429
Sponsor: Sen. Collins, Susan M. [R-ME]
Introduced: 2021-04-28 in the Senate
Policy area: Law
Subjects: Africa
Aviation and airports
Bankruptcy
Civil actions and liability
Corporate finance and management
Crime victims
Evidence and witnesses
Government information and archives
Government liability
Government trust funds
Libya
Middle East
Scotland
Terrorism
Transportation employees
United Kingdom

Summary:
action_date: 2021-04-28
text: 

Justice for the Living Victims of Lockerbie Act

 
This bill establishes a mechanism for compensating certain victims of the bombing of Pan American Flight 103 over Lockerbie, Scotland, on December 21, 1988.
 
The Office of Aviation and International Affairs must determine whether the bombing was a proximate cause of Pan American's bankruptcy. If the office finds such proximate cause, then the Department of the Treasury must establish a fund to compensate qualifying victims of the bombing (generally, former employees of Pan American who were part of an earlier lawsuit seeking compensation from Libya for the bombing).
 
The Foreign Claims Settlement Commission must establish a process for claimants to apply for compensation from the fund.



Legislative actions:
action_date: 2021-04-28
text: Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S2295-2296)
action_date: 2021-04-28
text: Introduced in Senate
Ceasing Undeserved Relief Benefits for Debt Collectors Act for 2021

Bill: 117-s-1430
Sponsor: Sen. Heinrich, Martin [D-NM]
Introduced: 2021-04-28 in the Senate
Policy area: Commerce
Subjects: Business expenses
Cardiovascular and respiratory health
Civil actions and liability
Debt collection
Emergency medical services and trauma care
Government lending and loan guarantees
Infectious and parasitic diseases
Small business
Wages and earnings

Summary:
action_date: 2021-04-28
text: 

Ceasing Undeserved Relief Benefits for Debt Collectors Act for 2021 or the CURB Debt Collectors Act

 
This bill makes debt collectors that have violated certain debt collection laws ineligible to receive loans under the Paycheck Protection Program established to support small business in response to COVID-19.


Legislative actions:
action_date: 2021-04-28
text: Read twice and referred to the Committee on Small Business and Entrepreneurship.
action_date: 2021-04-28
text: Introduced in Senate
Metropolitan Statistical Area Stabilization Act

Bill: 117-s-1431
Sponsor: Sen. Tester, Jon [D-MT]
Introduced: 2021-04-28 in the Senate
Policy area: Government Operations and Politics
Subjects: Census and government statistics
Urban and suburban affairs and development

Summary:
action_date: 2021-04-28
text: 

Metropolitan Statistical Area Stabilization Act

 
This bill prohibits the Office of Management and Budget from raising the minimum urban area population to qualify a metropolitan statistical area from 50,000. 


Legislative actions:
action_date: 2021-06-15
text: Committee on Banking, Housing, and Urban Affairs. Hearings held.
action_date: 2021-04-28
text: Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
action_date: 2021-04-28
text: Introduced in Senate
POWER ON Act of 2021

Bill: 117-s-1432
Sponsor: Sen. Cornyn, John [R-TX]
Introduced: 2021-04-28 in the Senate
Policy area: Energy
Subjects: Atmospheric science and weather
Congressional oversight
Electric power generation and transmission
Energy research
Energy storage, supplies, demand
Fires
Natural disasters
Public utilities and utility rates
Research administration and funding
Research and development

Summary:
action_date: 2021-04-28
text: 

Preventing Outages With Enhanced Resilience and Operations Nationwide Act of 2021 or the POWER ON Act of 2021

 
This bill provides incentives for enhancing the resilience of the electric power grid to natural disasters and strengthening the emergency response and management of the grid.
 
Specifically, the bill requires the Department of Energy (DOE) to establish an electric grid resilience program. Under the program, DOE must provide grants to states and Indian tribes for projects that enhance the physical resilience of the electric grid to natural disasters.
 
In addition, DOE must establish a research, development, demonstration, and commercial application program to enhance resilience and strengthen emergency response and management of the electric grid. Under the program, DOE must award grants to improve the resilience of the electric grid by developing technologies and capabilities to withstand and address the current and projected impact on electric grid infrastructure of natural disasters, such as wildfires.


Legislative actions:
action_date: 2021-04-28
text: Read twice and referred to the Committee on Energy and Natural Resources.
action_date: 2021-04-28
text: Introduced in Senate
Guarding Readiness Resources Act of 2021

Bill: 117-s-1433
Sponsor: Sen. Lee, Mike [R-UT]
Introduced: 2021-04-28 in the Senate
Policy area: Armed Forces and National Security
Subjects: Appropriations
Defense spending
Intergovernmental relations
Military facilities and property
National Guard and reserves
State and local finance
U.S. territories and protectorates

Summary:
action_date: 2021-04-28
text: 

Guarding Readiness Resources Act of 2021

 
This bill modifies the treatment of funds received by the National Guard Bureau as a reimbursement from a state or other U.S. territory (e.g., Guam) for the use of military property.
 
Specifically, the funds must be credited to (1) the appropriation, fund, or account used in incurring the obligation; or (2) an appropriation, fund, or account currently available for the purposes of which the expenditures were made.
 


Legislative actions:
action_date: 2021-04-28
text: Read twice and referred to the Committee on Armed Services.
action_date: 2021-04-28
text: Introduced in Senate
Protecting Americans from Dangerous Opioids Act

Bill: 117-s-1434
Sponsor: Sen. Manchin, Joe, III [D-WV]
Introduced: 2021-04-28 in the Senate
Policy area: Health
Subjects: Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Prescription drugs

Summary:
action_date: 2021-04-28
text: 

Protecting Americans from Dangerous Opioids Act

 This bill requires the Food and Drug Administration (FDA) to revoke approval for an opioid drug for every new opioid drug approved. (Opioids are drugs with effects similar to opium, such as certain pain medications.) In determining the drug for which to revoke approval, the FDA must prioritize revoking approval for drugs that are not abuse deterrent and consider the public health impact of drugs on the market.

Legislative actions:
action_date: 2021-04-28
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
action_date: 2021-04-28
text: Introduced in Senate
Affordable Prescriptions for Patients Act of 2021

Bill: 117-s-1435
Sponsor: Sen. Cornyn, John [R-TX]
Introduced: 2021-04-28 in the Senate
Policy area: Commerce
Subjects: Administrative remedies
Civil actions and liability
Competition and antitrust
Consumer affairs
Drug safety, medical device, and laboratory regulation
Federal Trade Commission (FTC)
Health
Health care costs and insurance
Inflation and prices
Intellectual property
Judicial review and appeals
Manufacturing
Prescription drugs

Summary:
action_date: 2021-04-28
text: 

Affordable Prescriptions for Patients Act of 2021 

 
This bill prohibits product hopping by drug manufacturers, authorizes the Federal Trade Commission to enforce this prohibition, and imposes limits on patent litigation involving biological products. 
 
Generally, 
product-hopping
 describes a situation where, when the patents on a reference drug (or biological product) expire, the manufacturer switches to a follow-on product that is covered by a later-expiring patent. Under this bill, a 
follow-on product
 is a modified version of the reference drug that shares an indication (what the drug is used for) with the reference drug.
 
The bill presumes product hopping has occurred when a reference drug manufacturer, after receiving notice that the Food and Drug Administration (FDA) has received an application to market a competing generic (or biosimilar) version, takes certain actions such as withdrawing the reference drug from the market and selling a follow-on product. 
 
A drug manufacturer may rebut these presumptions by demonstrating that its conduct was not intended to limit competition.
 
The bill also limits in certain instances the number of patents that a reference biological product manufacturer can assert in a patent infringement lawsuit against a company seeking to sell a biosimilar version. Specifically, if the biosimilar manufacturer completes certain actions as part of an abbreviated pathway to get FDA market approval, the bill limits, subject to exceptions and waivers, the number of certain types of patents that the reference product manufacturer may assert, such as patents filed more than four years after the reference product received market approval. 
 
 


Legislative actions:
action_date: 2021-07-29
text: Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
action_date: 2021-04-28
text: Read twice and referred to the Committee on the Judiciary.
action_date: 2021-04-28
text: Introduced in Senate
Changing the Culture of the FDA Act

Bill: 117-s-1436
Sponsor: Sen. Manchin, Joe, III [D-WV]
Introduced: 2021-04-28 in the Senate
Policy area: Health
Subjects: Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Food and Drug Administration (FDA)
Prescription drugs

Summary:
action_date: 2021-04-28
text: 

Changing the Culture of the FDA Act

 This bill requires the Food and Drug Administration to amend its mission statement to state that it is responsible for protecting the public health by considering the danger of addiction and overdose death when approving and regulating prescription opioid medications. (Opioid medications are drugs with effects similar to opium, such as certain pain medications.)

Legislative actions:
action_date: 2021-04-28
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
action_date: 2021-04-28
text: Introduced in Senate
Recognizing the Role of Direct Support Professionals Act

Bill: 117-s-1437
Sponsor: Sen. Hassan, Margaret Wood [D-NH]
Introduced: 2021-04-28 in the Senate
Policy area: Labor and Employment
Subjects: Disability assistance
Government information and archives
Health personnel
Home and outpatient care

Summary:
action_date: 2021-04-28
text: 

Recognizing the Role of Direct Support Professionals Act 

 
This bill requires the Office of Management and Budget to establish a separate category within the Standard Occupational Classification system for direct support professionals (i.e., individuals who provide services to promote independence in individuals with a disability) for data reporting purposes. 


Legislative actions:
action_date: 2021-04-28
text: Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
action_date: 2021-04-28
text: Introduced in Senate
Opioid Workforce Act of 2021

Bill: 117-s-1438
Sponsor: Sen. Hassan, Margaret Wood [D-NH]
Introduced: 2021-04-28 in the Senate
Policy area: Health
Subjects: Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Education programs funding
Health personnel
Health programs administration and funding
Hospital care
Medical education
Medicare
Mental health

Summary:
action_date: 2021-04-28
text: 

Opioid Workforce Act of 

2021

 
This bill increases the number of residency positions eligible for graduate medical education payments under Medicare for hospitals that have addiction or pain medicine programs, with an aggregate increase of 1,000 positions over a five-year period.


Legislative actions:
action_date: 2021-04-28
text: Read twice and referred to the Committee on Finance.
action_date: 2021-04-28
text: Introduced in Senate
FDA Accountability for Public Safety Act

Bill: 117-s-1439
Sponsor: Sen. Manchin, Joe, III [D-WV]
Introduced: 2021-04-28 in the Senate
Policy area: Health
Subjects: Congressional oversight
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Federal officials
Food and Drug Administration (FDA)
Government ethics and transparency, public corruption
Marketing and advertising
Prescription drugs

Summary:
action_date: 2021-04-28
text: 

FDA Accountability for Public Safety Act

 
This bill establishes additional procedures related to the market approval process for opioids. 
 
Under the bill, a Food and Drug Administration (FDA) advisory committee must make recommendations regarding supplemental applications for opioids. Current law requires only that an FDA committee make recommendations on new drug applications. 
 
The bill specifies that only the Commissioner of Food and Drugs may approve an opioid-related application against the recommendation of the committee. If the Commissioner approves such an application against a committee recommendation, the Commissioner must submit a report to Congress that includes (1) the evidence regarding patient safety that supports the Commissioner's decision, and (2) a disclosure of any potential conflicts of interest of FDA officials involved in the decision. The Commissioner must also testify before Congress regarding the decision, upon request. The drug in question may not be sold until the Commissioner has submitted the required report.


Legislative actions:
action_date: 2021-04-28
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
action_date: 2021-04-28
text: Introduced in Senate